Class II · Moderate risk Terminated
Cefdinir for Oral Suspension USP
Reason Defective container: lack of seal integrity.
Cefdinir for Oral Suspension USP
Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.
Why it was recalled
Presence of Foreign substance: identified as a dead ant.
What was recalled
Cefdinir for Oral Suspension USP, 250 mg/5mL,100 mL bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202, United States, Manufactured by: Lupin Limited, Mandideep 462 046 INDIA, NDC 68180-723-10
- Recalling firm
- Lupin Pharmaceuticals Inc.
- NDC code
- 68180-723-10
- Origin
- MD, United States
- Initiated by
- Voluntary: Firm initiated
- FDA recall number
- D-0305-2020
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Other Cefdinir recalls
See all
Class II · Moderate risk Terminated
Cefdinir for Oral Suspension USP 125 mg/5 mL
Reason Presence of foreign substance: Product complaint of foreign material in reconstituted bottle.
Class II · Moderate risk Terminated
Cefdinir for Oral Suspension USP 250 mg/5 mL
Reason Presence of foreign substance: Product complaint of foreign material in reconstituted bottle.
Class II · Moderate risk Terminated
Cefdinir for Oral Suspension USP
Reason Superpotent Drug: Out-of-specification (OOS) result observed in an assay test of retention samples.
Class III · Low risk Terminated
Cefdinir for Oral Suspension USP
Reason Presence of Foreign substance: identified as a dead ant.
Get an alert if your medication is recalled
Tell us which medications you take. If the FDA recalls one, we email you - in plain English, with what to do. Free.